CRISPR Therapeutics Traded Sideways and Down for 12 Months: One Wall Street Pro Expects 85% Gains Soon
CRISPR Therapeutics owns the only approved gene therapy of its kind, yet the stock sits far below where Wall Street thinks it belongs. One analyst sees a path to gains that would embarrass the broader market, but the numbers tell…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Read MoreMeta Just Blew Past Wall Street’s $750 Target. Where Does It Go Now?
Meta just shattered Wall Street’s consensus price target on the back of a 37% monthly surge, but with free cash flow collapsing 91% and capex ballooning toward $145 billion, the real debate is whether the AI spending spree pays off…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
» Read more about: Meta Just Blew Past Wall Street’s $750 Target. Where Does It Go Now? »
Read MoreWall Street Bulls Look Optimistic About CleanSpark (CLSK): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock’s price, do they really matter?
Let’s take a look at what these Wall Street heavyweights have to say about CleanSpark (CLSK) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.
» Read more about: Wall Street Bulls Look Optimistic About CleanSpark (CLSK): Should You Buy? »
Read MoreThe True Enemy of Index Investing Is Not a 'Market Crash'—A Market Where Your Assets Shrink No Matter How Much You Invest
I believe index investing is an excellent means of building wealth.
It is low-cost and allows for diversification across a wide range of companies.
You do not need to analyze companies one by one like with individual stocks, and you can benefit from long-term economic growth.
I myself have no intention of denying index investing.
Read More[Thursday] Bank of Japan makes a surprise rate hike for the first time in 3 months. What I, with a 1.15% variable interest rate, am thinking about now
Hello. This is an account aiming for +1 million yen/year in dividends.
How did you spend your Silver Week holidays?
I was working, but two major developments occurred during this time.
I will start from here today with the review I promised. What has happened over these past 10 days
FOMC (Sept 15-16,
Read MoreThe Burst
Could Alphabet Become the World’s Largest Company
Alphabet (NASDAQ: GOOGL) is already a giant, but it may still be in the early innings of its growth story. With a market capitalization hovering just shy of $3 trillion, it is within striking distance of becoming the world’s next $4 trillion stock.
What makes this more than just speculation is that several potential roadblocks have recently cleared,
» Read more about: Could Alphabet Become the World’s Largest Company »
Read MoreThe Ivy
Why Bill Ackman Is All-In on Uber
Uber controls as much as 75% of the U.S. ridesharing market, while Lyft holds roughly 25%.
This dominance creates a powerful network effect, more riders attract more drivers, which in turn attracts even more riders. That feedback loop makes Uber’s position extremely difficult to challenge.
Ackman prefers companies with natural barriers to entry,
» Read more about: Why Bill Ackman Is All-In on Uber »
Read MoreThe Spotlight
1 Dividend Powerhouse Built for the Long Haul
When investors talk about reliability in the energy sector, Enbridge (NYSE: ENB) belongs in a class of its own. For over seven decades, this Canadian pipeline and utility powerhouse has paid a dividend, an almost unheard-of feat in an industry known for boom-and-bust cycles.
Even more impressive is that it has raised its dividend for 30 consecutive years,
» Read more about: 1 Dividend Powerhouse Built for the Long Haul »